ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 218 filers reported holding ZAI LAB LTD in Q1 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $469,964 | +8.6% | 14,130 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $432,802 | -40.1% | 14,130 | -33.1% | 0.00% | -50.0% |
| Q3 2022 | $722,000 | +22.6% | 21,114 | +24.1% | 0.00% | +33.3% |
| Q2 2022 | $589,000 | -15.3% | 17,008 | +7.6% | 0.00% | 0.0% |
| Q1 2022 | $695,000 | -29.4% | 15,813 | +1.6% | 0.00% | 0.0% |
| Q4 2021 | $984,000 | -36.0% | 15,560 | +6.6% | 0.00% | -50.0% |
| Q3 2021 | $1,538,000 | -37.7% | 14,594 | +4.5% | 0.01% | -33.3% |
| Q2 2021 | $2,470,000 | +27.5% | 13,960 | -3.9% | 0.01% | +12.5% |
| Q1 2021 | $1,938,000 | -4.2% | 14,525 | -6.9% | 0.01% | 0.0% |
| Q4 2020 | $2,024,000 | +80.6% | 15,597 | +15.7% | 0.01% | +60.0% |
| Q3 2020 | $1,121,000 | +20.0% | 13,483 | +18.6% | 0.01% | 0.0% |
| Q2 2020 | $934,000 | +167.6% | 11,366 | +67.8% | 0.01% | +150.0% |
| Q1 2020 | $349,000 | – | 6,775 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRILLIANCE ASSET MANAGEMENT LTD | 1,631,887 | $71,770,000 | 28.24% |
| Zeal Asset Management Ltd | 351,829 | $15,234,000 | 19.86% |
| Tree Line Advisors (Hong Kong) Ltd. | 460,000 | $20,231,000 | 11.97% |
| INDUS CAPITAL PARTNERS, LLC | 291,026 | $12,799,000 | 5.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 78,958 | $16,958,000 | 3.82% |
| HSG Holding Ltd | 694,634 | $30,550,000 | 3.81% |
| EcoR1 Capital, LLC | 2,223,212 | $97,777,000 | 3.06% |
| Segantii Capital Management Ltd | 2,252,274 | $99,055,000 | 2.86% |
| Privium Fund Management B.V. | 226,752 | $9,973,000 | 2.20% |
| Genesis Investment Management, LLP | 820,352 | $36,079,000 | 2.12% |